Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism

Br J Dermatol. 2007 Jun;156(6):1353-6. doi: 10.1111/j.1365-2133.2007.07869.x. Epub 2007 Apr 17.

Abstract

We report an activating fibroblast growth factor receptor 3 (FGFR3) mutation (R248C) occurring in a verrucous epidermal naevus, and not found in other tissues, in a girl with mild facial dysmorphism. We demonstrate the presence of the mutation in keratinocytes cultured from the naevus and we speculate that a low level of the mutation in other tissues may account for her facial dysmorphism. The possibility that the mutation is present in other tissues implies a possible risk to her future offspring.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Craniosynostoses / genetics
  • Facial Asymmetry / genetics*
  • Female
  • Humans
  • Mosaicism*
  • Nevus, Pigmented / genetics*
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*

Substances

  • Receptor, Fibroblast Growth Factor, Type 3